We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NGVT market cap is 1.68B. The company's latest EPS is USD -0.1486 and P/E is -311.91.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 446M | 371.7M | 340.1M | 390.6M | 376.9M |
| Operating Income | 56.5M | -111.7M | -17.4M | -287.5M | -2.3M |
| Net Income | 25.2M | -116.8M | -56M | -283.7M | -107.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.29B | 1.22B | 1.39B | 1.67B | 1.69B |
| Operating Income | 270.1M | 273.2M | 290.4M | 322.2M | 82.6M |
| Net Income | 183.7M | 181.4M | 118.1M | 211.6M | -5.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.77B | 2.62B | 2.57B | 2.28B | 2.21B |
| Total Liabilities | 2.05B | 1.99B | 2B | 1.99B | 2B |
| Total Equity | 718.7M | 631.4M | 568.2M | 284.8M | 214.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.14B | 2.33B | 2.47B | 2.74B | 2.62B |
| Total Liabilities | 1.61B | 1.69B | 1.8B | 2.04B | 1.99B |
| Total Equity | 530.8M | 642.1M | 673.8M | 698.3M | 631.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 160.5M | 205.1M | -12.1M | 17.6M | 64.1M |
| Investing | -56.3M | -77.3M | -16.3M | -34.1M | -51.5M |
| Financing | -93.4M | -99.9M | 23.4M | 33.7M | 27.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 275.7M | 352.4M | 293M | 313.1M | 205.1M |
| Investing | -658.3M | -110.6M | -140.6M | -553.9M | -77.3M |
| Financing | 369.2M | -50.2M | -133.1M | 48.1M | -99.9M |
| Market Cap | 1.68B |
| Price to Earnings Ratio | -311.91 |
| Price to Sales Ratio | 1 |
| Price to Cash Ratio | 17.57 |
| Price to Book Ratio | 2.67 |
| Dividend Yield | - |
| Shares Outstanding | 36.35M |
| Average Volume (1 week) | 213.64k |
| Average Volume (1 Month) | 216.87k |
| 52 Week Change | 11.98% |
| 52 Week High | 56.295 |
| 52 Week Low | 30.8995 |
| Spread (Intraday) | 10.62 (20.88%) |
| Company Name | Ingevity Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.ingevity.com |
| Industry | chemicals & allied products (2800) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
